title: [Perinatality in the context of addictions].
abstract: We must remove bad representations the medical team has upon the pregnant drug users and the same way in reverse. Opiate substitution treatment (OST) improves prenatal prognosis for both mother and child. There is no need to change OST for a stabilized woman discovering pregnancy. Nevertheless, buprenorphine appears to be first-range medication. OST posology is the most important for prenatal prognosis. Practician must never hesitate to adapt it whether increasing or fractionate it. Neonatal abstinence syndrome (NAS) is not linked with OST's posology. OST is not contra-indicated for breast-feeding. Breast-feeding should be encouraged. It does not treat or cure NAS but allows a skin-to-skin contact that could lessens an occurring withdrawal.
authors.affiliation: CHU G. Montpied, SATIS, pôle de psychiatrie, 63003 Clermont-Ferrand cedex 1, France. laure.nacache@chu-lyon.fr
authors.forename: Pascal
authors.initials: P
authors.lastname: Courty
authors.forename: Laure
authors.initials: L
authors.lastname: Nacache
mesh_terms: D016739:Behavior, Addictive / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009357:Neonatal Abstinence Syndrome / Q000188:drug therapy*; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*